Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A Practical Guide Gary DeedRoy RasalamNick Forgione Practical Approach Open access 21 October 2019 Pages: 1987 - 1994
Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review Scott M. WilliamsAikaterini EleftheriadouJohn P. H. Wilding Review Open access 24 September 2019 Pages: 1995 - 2021
Correction to: Cardiac Autonomic Neuropathy in Obesity, Metabolic Syndrome and Prediabetes: A Narrative Review Scott M. WilliamsAikaterini EleftheriadouJohn P. H. Wilding Correction Open access 04 October 2019 Pages: 2023 - 2023
Is There a Role for Informal Caregivers in the Management of Diabetic Foot Ulcers? A Narrative Review Grace MessengerNehad TahaAli M. Aldibbiat Review Open access 26 September 2019 Pages: 2025 - 2033
Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management Sanjay KalraSameer AggarwalDeepak Khandelwal Review Open access 03 October 2019 Pages: 2035 - 2044
Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study Takeshi OsonoiAtsuko TamasawaMiyoko Saito Original Research Open access 10 September 2019 Pages: 2045 - 2059
Prevalence and the Association of Body Mass Index and Other Risk Factors with Prediabetes and Type 2 Diabetes Among 50,867 Adults in China and Sweden: A Cross-Sectional Study Yue ZhangAiliana SantosaGenming Zhao Original Research Open access 11 September 2019 Pages: 2061 - 2077
Forecasting the Prevalence of Diabetes Mellitus Using Econometric Models Assel MukashevaNurbek SaparkhojayevSanjay Kalra Original Research Open access 13 September 2019 Pages: 2079 - 2093
Effect of Individualized Dietary Intervention on Oxidative Stress in Patients with Type 2 Diabetes Complicated by Tuberculosis in Xinjiang, China Liyun HeGuoming ZhangGuiyun Meng Original Research Open access 19 September 2019 Pages: 2095 - 2105
Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study Rikke TetzschnerAjenthen G. RanjanKirsten Nørgaard Original Research Open access 24 September 2019 Pages: 2107 - 2113
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections Sheyda SofizadehHenrik ImbergMarcus Lind Original Research Open access 28 September 2019 Pages: 2115 - 2130
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK Dominik LautschTongtong WangSwapnil N. Rajpathak Original Research Open access 04 October 2019 Pages: 2131 - 2137
Index of Plantar Pressure Alters with Prolonged Diabetes Duration Lei XuHui ZengWeiping Jia Original Research Open access 08 October 2019 Pages: 2139 - 2152
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease Mafalda RamosVolker FoosMark Lamotte Original Research Open access 10 October 2019 Pages: 2153 - 2167
Acanthosis Nigricans in the Knuckles of Infants: A Novel Clinical Marker of High Metabolic Risk René Rodríguez-GutiérrezManuel E. de la O-CavazosJosé Gerardo González-González Original Research Open access 10 October 2019 Pages: 2169 - 2181
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis Solomon NuhohoJatin GuptaAbby Paine Original Research Open access 10 October 2019 Pages: 2183 - 2199
Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials Atsunori KashiwagiMarina V. ShestakovaJohn P. H. Wilding Original Research Open access 12 October 2019 Pages: 2201 - 2217
Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus Yuichiro ItoJames Van SchyndleTomomi Kimura Original Research Open access 15 October 2019 Pages: 2219 - 2231
Drug Utilization Patterns in Patients with Diabetes Initiating Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Japan: A Multi-Database Study (2014–2017) Yuichiro ItoJames Van SchyndleTomomi Kimura Original Research Open access 18 October 2019 Pages: 2233 - 2249
How Serious is the Economic Burden of Diabetes Mellitus in Hainan Province? A Study Based on “System of Health Account 2011” Yuanyuan DongChunping LiuXin Wang Original Research Open access 18 October 2019 Pages: 2251 - 2263
Mechanism of Placenta Damage in Gestational Diabetes Mellitus by Investigating TXNIP of Patient Samples and Gene Functional Research in Cell Line SarinaDong Fang LiLan Yu Original Research Open access 26 October 2019 Pages: 2265 - 2288
Impact of Carbohydrate on Glucose Variability in Patients with Type 1 Diabetes Assessed Through Professional Continuous Glucose Monitoring: A Retrospective Study Yi-Hsuan LinYu-Yao HuangChia-Hung Lin Original Research Open access 28 October 2019 Pages: 2289 - 2304
Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study) Alexandria Ratzki-LeewingEhsan Parvaresh RiziStewart B. Harris Brief Report Open access 09 September 2019 Pages: 2305 - 2311
Type 2 Diabetes Mellitus and Menopausal Hormone Therapy: An Update Stavroula A. PaschouNikolaos Papanas Brief Report Open access 24 September 2019 Pages: 2313 - 2320
Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis Hiren PatelKashif MunirManige Konig Brief Report Open access 11 October 2019 Pages: 2321 - 2330